Skip to main content

. 1966 Aug;27(2):277–285. doi: 10.1111/j.1476-5381.1966.tb01662.x

Dimethyl isopropylmethoxamine: a selective beta-receptor blocking agent.

PMCID: PMC1510826 PMID: 5967366

277

Images in this article

Fig. 1
on p.279

Fig. 2
on p.280

Fig. 3
on p.281

Fig. 4
on p.281

Fig. 5
on p.282

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

AHLQUIST R. P., LEVY B. Andrenergic receptive mechanism of canine ileum. J Pharmacol Exp Ther. 1959 Oct;127:146–149. [PubMed] [Google Scholar]
BAY E., COTTEN M. D. Direct measurement of changes in cardiac contractile force; relationship of such measurements to stroke work, isometric pressure gradient and other parameters of cardiac function. Am J Physiol. 1956 Sep;187(1):122–134. doi: 10.1152/ajplegacy.1956.187.1.122. [DOI] [PubMed] [Google Scholar]
BLACK J. W., CROWTHER A. F., SHANKS R. G., SMITH L. H., DORNHORST A. C. A NEW ADRENERGIC BETARECEPTOR ANTAGONIST. Lancet. 1964 May 16;1(7342):1080–1081. doi: 10.1016/s0140-6736(64)91275-9. [DOI] [PubMed] [Google Scholar]
BLACK J. W., STEPHENSON J. S. Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide). Lancet. 1962 Aug 18;2(7251):311–314. doi: 10.1016/s0140-6736(62)90103-4. [DOI] [PubMed] [Google Scholar]
BONIFACE K. J., BRODIE O. J., WALTON R. P. Resistance strain gauge arches for direct measurement of heart contractile force in animals. Proc Soc Exp Biol Med. 1953 Nov;84(2):263–266. doi: 10.3181/00379727-84-20612. [DOI] [PubMed] [Google Scholar]
BURNS J. J., COLVILLE K. I., LINDSAY L. A., SALVADOR R. A. BLOCKADE OF SOME METABOLIC EFFECTS OF CATECHOLAMINES BY N-ISOPROPYL METHOXAMINE (B.W. 61-43). J Pharmacol Exp Ther. 1964 May;144:163–171. [PubMed] [Google Scholar]
Kvam D. C., Riggilo D. A., Lish P. M. Effect of some new beta-adrenergic blocking agents on certain metabolic responses to catecholamines. J Pharmacol Exp Ther. 1965 Aug;149(2):183–192. [PubMed] [Google Scholar]
LEVY B., AHLQUIST R. P. An analysis of adrenergic blocking activity. J Pharmacol Exp Ther. 1961 Aug;133:202–210. [PubMed] [Google Scholar]
LEVY B. ALTERATIONS OF ADRENERGIC RESPONSES BY N-ISOPROPYLMETHOXAMINE. J Pharmacol Exp Ther. 1964 Oct;146:129–138. [PubMed] [Google Scholar]
LEVY B. Adrenergic blockade produced by the dichloro analogs of epinephrine, arterenol and isoproterenol. J Pharmacol Exp Ther. 1959 Oct;127:150–156. [PubMed] [Google Scholar]
LEVY B., TOZZI S. THE ADRENERGIC RECEPTIVE MECHANISM OF THE RAT UTERUS. J Pharmacol Exp Ther. 1963 Nov;142:178–184. [PubMed] [Google Scholar]
Levy B. The adrenergic blocking activity of N-tert.-butylmethoxamine (butoxamine). J Pharmacol Exp Ther. 1966 Mar;151(3):413–422. [PubMed] [Google Scholar]
Lish P. M., Weikel J. H., Dungan K. W. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists. J Pharmacol Exp Ther. 1965 Aug;149(2):161–173. [PubMed] [Google Scholar]
MORAN N. C., PERKINS M. E. Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol. J Pharmacol Exp Ther. 1958 Nov;124(3):223–237. [PubMed] [Google Scholar]
POWELL C. E., SLATER I. H. Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. J Pharmacol Exp Ther. 1958 Apr;122(4):480–488. [PubMed] [Google Scholar]
SALVADOR R. A., COLVILLE K. I., APRIL S. A., BURNS J. J. INHIBITION OF LIPID MOBILIZATION BY N-ISOPROPYL METHOXAMINE (B.W. 61-43). J Pharmacol Exp Ther. 1964 May;144:172–180. [PubMed] [Google Scholar]
Stanton H. C., Kirchgessner T., Parmenter K. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists. J Pharmacol Exp Ther. 1965 Aug;149(2):174–182. [PubMed] [Google Scholar]

ACTIONS

RESOURCES